The COVID-19 pandemic has become a catalyst for the accelerated adoption of virtual health. With rising demands for remote healthcare, it’s no surprise that Deloitte predicts that global spending on mobile mental health applications will reach the US $500 million in 2022, a 20% increase from last year. In this article, we assess the current state of […]

Let’s take a look at the current state of things in the Pharma industry, and see if this data can prove useful when answering the question: are we there yet to make a move and introduce something new

Let’s take a look at the market data and see what kind of conclusions we can draw from this trend (given the uncertainty the market is experiencing at the moment).

With a much higher number of users than recently, the most successful solutions hone the user experience of their Telehealth platforms, as it becomes a truly competitive edge.

Clinics and medical facilities continue to decrease the potential exposure of patients to COVID-19, and thus, the full capacity will not return to its previous levels any time soon.

Let’s take a look at the reasons why patients and doctors may not like Telemedicine, and what can be done about it.